As shown in Figure 6, metformin treatment was able to reduce significantly GSK3β (Ser9) phosphorylation, suggesting that metformin can affect both β-catenin expression and stability in endometrial cancer cells. The gene discussed is GSK3B; the disease is endometrial cancer.